Northern,WI 4/26/2012
(CEO InterviewSeries) -- Welcome to another edition of The Street Beat’s CEO Interview Series with your host Bolton Flautt interviews Cellceutix CEO Leo Ehrlich. Cellceutix is a biopharmaceutical company developing small molecule drugs to treat severe medical conditions, including drug-resistant cancers. Cellceutix trades under the ticker (OTCBB:CTIX).
Full Disclaimer Here